|
Daunorubicin Hydrochloride Clinical Trials
7 actively recruiting trials across 2 locations
No change since July 2026
Also known as: Cerubidin, Cerubidine, Cloridrato de Daunorubicina, Daunoblastin, Daunoblastina +10 more
Pipeline
Phase 2: 4Phase 3: 3
Top Sponsors
- National Cancer Institute (NCI)3
- Children's Oncology Group2
- City of Hope Medical Center1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer7
- Acute Myeloid Leukemia4
- Acute Myeloid Leukemia, Myelodysplasia-Related2
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm2
- B Acute Lymphoblastic Leukemia2
Birmingham, Alabama6 trials
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Children's Hospital of Alabama
Phase 3
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
University of Alabama at Birmingham Cancer Center
Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Children's Hospital of Alabama
Phase 3
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
University of Alabama at Birmingham Cancer Center
Phase 2
Phoenix, Arizona1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.